Relationship between mean platelet volume levels and subclinical target organ damage in newly diagnosed hypertensive patients

References

• Lande K, Os I, Kjeldsen SE, Westheim A, Hjermann I, Eide I, . Increased platelet size and release reaction in essential hypertension. J Hypertens. 1987;5:401–406.
   PubMed Web of Science ®Google Scholar
• Lande K, Kjeldsen SE, Os I, Westheim A, Hjermann I, Eide I, . Increased platelet and vascular smooth muscle reactivity to low-dose adrenaline infusion in mild essential hypertension. J Hypertens. 1988;6:219–225.
   PubMed Web of Science ®Google Scholar
• Kaya MG, Yarlioglues M, Gunebakmaz O, Gunturk E, Inanc T, Dogan A, . Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis. 2010;209:278–282.
   PubMed Web of Science ®Google Scholar
• Nadar S, Lip GY. The prothrombotic state in hypertension and the effects of antihypertensive treatment. Curr Pharm Des. 2003;9:1715–1732.
   PubMed Web of Science ®Google Scholar
• Islim IF, Bareford D, Ebanks M, Beevers DG. The role of platelets in essential hypertension. Blood Press. 1995;4:199–214. Review.
   PubMedGoogle Scholar
• Lip GY. Target organ damage and the prothrombotic state in hypertension. Hypertension. 2000;36:975–977.
   PubMed Web of Science ®Google Scholar
• Kamath S, Blann AD, Lip GY. Platelet activation: Assessment and quantification. Eur Heart J. 2001;22:1561–1571.
   PubMed Web of Science ®Google Scholar
• Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996; 7:157–161.
   PubMed Web of Science ®Google Scholar
• Park Y, Schoene N, Haris W. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets. 2002;13:301–306.
   PubMed Web of Science ®Google Scholar
• Inanc T, Kaya MG, Yarlioglues M, Ardic I, Ozdogru I, Dogan A, . The mean platelet volume in patients with non-dipper hypertension compared to dippers and normotensives. Blood Press. 2010;19:81–85.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, . Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292:2350–2356.
   PubMed Web of Science ®Google Scholar
• Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implication of echocardiographic determined left ventricular mass in the Framingham Heart Study. N Eng J Med. 1990;322:1561–1556.
   PubMed Web of Science ®Google Scholar
• Vakili BA, Okin PM, Devereux RB. Prognostic significance of left ventricular hypertrophy. Am Heart J. 2001;141: 334–341.
   PubMed Web of Science ®Google Scholar
• De Simone G, Verdecchia P, Pede S, Gorini M, Maggioni AP. Prognosis of inappropriate left ventricular mass in hypertension The MAVI study. Hypertension. 2002;40:470–476.
   PubMed Web of Science ®Google Scholar
• Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, . Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk In Communities (ARIC) study. Am J Epidemiol. 1997;146:483–494.
   PubMed Web of Science ®Google Scholar
• Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimamedial thickness is related to cardiovascular risk factors measured from childhood through middle age. Circulation. 2001; 104:2814–2819.
   Web of Science ®Google Scholar
• Leoncini G, Sacchi G, Ravera M, Viazzi F, Ratto E, Vettoretti S, . Microalbuminuria is an integrated marker of subclinic organ damage in primary hypertension. J Hum Hypertens. 2002;16:399–404.
   PubMed Web of Science ®Google Scholar
• Nadar SK, Tayebjee MH, Messerli F, Lip GY. Target organ damage in hypertension: Pathophysiology and implications for drug therapy. Curr Pharm Des. 2006;12:1581–1592.
   PubMed Web of Science ®Google Scholar
• Pizzulli L, Yang A, Martin JF, Lüderitz B. Changes in platelet size and count in unstable angina pectoris compared to stable or non-cardiac chest pain. Eur Heart J. 1998;19:80–84.
   PubMed Web of Science ®Google Scholar
• Kostrubiec M, Labyk A, Pedowska-Wloszek J, Hrynkiewicz Szymanska A, Jankowski K, Pacho S, . Mean platelet volume predicts early death in acute pulmonary embolism. Heart. 2009 Nov 11. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Bath P, Algert C, Chapman N, Neal B. Association of mean platelet volume with risk of stroke among 3134 individuals with history of CVD. Stroke. 2004;35:622–626.
   PubMed Web of Science ®Google Scholar
• Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, . Mean platelet volume as a predictor of cardiovascular risk: A systematic review and meta-analysis. J Thromb Haemost 2010;8:148–156.
   PubMed Web of Science ®Google Scholar
• Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY Platelet indexes in relation to target organ damage in high-risk hypertensive patients: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol. 2004; 44:415–422.
   PubMed Web of Science ®Google Scholar
• Kalaitzidis R, Bakris G. Pathogenesis and treatment of microalbuminuria in patients with diabetes: The road ahead. J Clin Hypertens. 2009;11:636–643.
   Web of Science ®Google Scholar
• Guagnano MT, Ferroni P, Santilli F, Paoletti V, Manigrasso MR, Pescara L, . Determinants of platelet activation in hypertensives with microalbuminuria. Free Radic Biol Med. 2009;46:922–927.
   PubMed Web of Science ®Google Scholar
• Ferroni P, Guagnano MT, Falco A, Paoletti V, Manigrasso MR, Michetti N, . Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria. Clin Sci. 2008;114:449–455.
   PubMed Web of Science ®Google Scholar
• Hekimsoy Z, Payzin B, Ornek T, Kando an G. Mean platelet volume in Type 2 diabetic patients. J Diabetes Complications. 2004;18:173–176.
   PubMed Web of Science ®Google Scholar
• Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, . Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2004;15:475–478.
   PubMed Web of Science ®Google Scholar
• Jurcut R, Arsenescu I, Pu cariu T, Usc tescu V, Jurcu C, Apetrei E, . Is interleukin-18 correlated with endothelial dysfunction and platelet activation in patients with unstable angina? Rom J Intern Med. 2005;43:199–209.
   PubMedGoogle Scholar
• De Luca G, Santagostino M, Secco GG, Cassetti E, Giuliani L, Franchi E, . Mean platelet volume and the extent of coronary artery disease: Results from a large prospective study. Atherosclerosis. 2009;206:292–297.
   PubMed Web of Science ®Google Scholar
• Gabbasov Z, Parfyonova Y, Popov E, Gavrilov I, Anuchin V, Dubov P, . Associations of platelet function in hypertensive patients with left ventricular hypertrophy, transient myocardial ischemia, and coronary artery disease. Platelets. 1998;9:191–195.
   PubMed Web of Science ®Google Scholar
• Lip GY, Blann AD. Associations of platelet function in hypertensive patients with left ventricular hypertrophy. Platelets. 1999;10:71–72.
   PubMed Web of Science ®Google Scholar
• Yabanoglu S, Akkiki M, Seguelas MH, Mialet-Perez J, Parini A, Pizzinat N. Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors. J Mol Cell Cardiol. 2009;46:518–525.
   PubMed Web of Science ®Google Scholar
• Wang C, Wu LL, Liu J, Zhang ZG, Fan D, Li L. Crosstalk between angiotensin II and platelet derived growth factor-BB mediated signal pathways in cardiomyocytes. Chin Med J. 2008;121:236–240.
   PubMed Web of Science ®Google Scholar
• Scuteri A, Cacciafesta M, De Propris AM, Di Bernardo MG, Recchi D, Celli V, . Platelet size and left ventricular hypertrophy in hypertensive patients over 50 years of age. Eur J Clin Invest. 1995;25:874–876.
   PubMed Web of Science ®Google Scholar
• Rifai N, Ridker PM. High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease. Clin Chem. 2001;47:403–411.
   PubMed Web of Science ®Google Scholar
• Tsioufis C, Dimitriadis K, Andrikou E, Thomopoulos C, Tsiachris D, Stefanadi E, . ADMA, C-reactive protein, and albuminuria in untreated essential hypertension: A cross-sectional study. Am J Kidney Dis 2010 Feb 25 [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Cao JJ, Arnold AM, Manolio TA, Polak JF, Psaty BM, Hirsch CH, . Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: The Cardiovascular Health Study. Circulation. 2007;116:32–38.
   PubMed Web of Science ®Google Scholar
• Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, Chaves PH, . C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: The Cardiovascular Health Study. Circulation. 2003;108:166–170.
   PubMed Web of Science ®Google Scholar
• Yazici S, Yazici M, Erer B, Erer B, Calik Y, Ozhan H, Ataoglu S. The platelet indices in patients with rheumatoid arthritis: Mean platelet volume reflects disease activity. Platelets. 2010; 21:122–125.
   PubMed Web of Science ®Google Scholar
• Coban E, Yazicioglu G, Berkant Avci A, Akcit F. The mean platelet volume in patients with essential and white coat hypertension. Platelets. 2005;16:435–438.
   PubMed Web of Science ®Google Scholar
• Manios E, Tsagalis G, Tsivgoulis G, Barlas G, Koroboki E, Michas F, . Time rate of blood pressure variation is associated with impaired renal function in hypertensive patients. J Hypertens. 2009 Jul 30 [Epub ahead of print].
   PubMedGoogle Scholar
• Ekart R, Hojs R, Pecovnik-Balon B, Bevc S, Dvorsak B. Blood pressure measurements and carotid intima media thickness in hemodialysis patients. Ther Apher Dial. 2009;13: 288–293.
   PubMed Web of Science ®Google Scholar
• Ozawa M, Tamura K, Okano Y, Matsushita K, Ikeya Y, Masuda S, . Blood pressure variability as well as blood pressure level is important for left ventricular hypertrophy and brachial–ankle pulse wave velocity in hypertensives. Clin Exp Hypertens. 2009;31:669–679.
   PubMed Web of Science ®Google Scholar
• Kjeldsen SE, Weder AB, Egan B, Neubig R, Zweifler AJ, Julius S. Effect of circulating epinephrine on platelet function and hematocrit. Hypertension. 1995;25:1096–105.
   PubMed Web of Science ®Google Scholar
• Dastjerdi MS, Emami T, Najafian A, Amini M. Mean platelet volume measurement, EDTA or citrate? Hematology. 2006; 11:317–319.
   PubMed Web of Science ®Google Scholar
• Macey M, Azam U, McCarthy D, Webb L, Chapman ES, Okrongly D, . Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology systems. Clin Chem. 2002;48:891–899.
   PubMed Web of Science ®Google Scholar